Ö1 Wissen aktuell
382 - Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Folgen
382-
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Gehört
381-
Ep. 371 - Moving faster at the academia-industry interface
Gehört
380-
Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
Gehört
379-
Ep. 369 - ASCO advances, China innovation & U.S. science under threat
Gehört
378-
